SG11201810360YA - Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative - Google Patents

Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative

Info

Publication number
SG11201810360YA
SG11201810360YA SG11201810360YA SG11201810360YA SG11201810360YA SG 11201810360Y A SG11201810360Y A SG 11201810360YA SG 11201810360Y A SG11201810360Y A SG 11201810360YA SG 11201810360Y A SG11201810360Y A SG 11201810360YA SG 11201810360Y A SG11201810360Y A SG 11201810360YA
Authority
SG
Singapore
Prior art keywords
kinase
independently
hydrogen atom
broken line
same
Prior art date
Application number
SG11201810360YA
Other languages
English (en)
Inventor
Tetsuya Sugimoto
Toshihiro Sakamoto
Fuyuki Yamamoto
Yu KOBAYAKAWA
Naoki EGASHIRA
Koji Ichikawa
Takumitsu Machida
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of SG11201810360YA publication Critical patent/SG11201810360YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11201810360YA 2016-05-20 2017-05-19 Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative SG11201810360YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016101599 2016-05-20
PCT/JP2017/018825 WO2017200087A1 (fr) 2016-05-20 2017-05-19 Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one

Publications (1)

Publication Number Publication Date
SG11201810360YA true SG11201810360YA (en) 2018-12-28

Family

ID=60325930

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810360YA SG11201810360YA (en) 2016-05-20 2017-05-19 Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative

Country Status (22)

Country Link
US (1) US10538528B2 (fr)
EP (1) EP3459953B1 (fr)
JP (1) JP6576553B2 (fr)
KR (1) KR102149734B1 (fr)
CN (1) CN109153681B (fr)
AU (1) AU2017265769B9 (fr)
BR (1) BR112018073721B1 (fr)
CA (1) CA3024831C (fr)
DK (1) DK3459953T3 (fr)
ES (1) ES2882018T3 (fr)
HK (1) HK1259613A1 (fr)
HU (1) HUE055846T2 (fr)
MA (1) MA45048A (fr)
MX (1) MX2018014022A (fr)
MY (1) MY185962A (fr)
PH (1) PH12018502411A1 (fr)
PL (1) PL3459953T3 (fr)
PT (1) PT3459953T (fr)
RU (1) RU2713181C1 (fr)
SG (1) SG11201810360YA (fr)
TW (2) TWI732187B (fr)
WO (1) WO2017200087A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240089357A (ko) * 2021-10-13 2024-06-20 다이호야쿠힌고교 가부시키가이샤 조절장애 mapk 및/또는 pi3k 경로를 갖는 암을 갖는 대상체를 위한 치료 방법
CN118525022A (zh) * 2022-01-27 2024-08-20 西藏海思科制药有限公司 一种氮杂并环衍生物及其在医药上的应用
TW202421127A (zh) * 2022-07-05 2024-06-01 日商大鵬藥品工業股份有限公司 ５Ｈ－吡咯并〔２，３－ｄ〕嘧啶－６（７Ｈ）－酮及其鹽體之結晶
CN115850244B (zh) * 2023-02-24 2023-05-16 成都大学 一种托吡司他的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2563699C (fr) * 2004-04-23 2014-03-25 Exelixis, Inc. Modulateurs de kinase et methode d'utilisation
GB0608184D0 (en) * 2006-04-25 2006-06-07 Astex Therapeutics Ltd Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
US8915177B2 (en) * 2008-08-08 2014-12-23 Nestec S.A. Beverage machine with carrying handle and configurable appearance and side functions
AR074072A1 (es) * 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
CN102574852B (zh) * 2009-10-23 2014-06-25 伊莱利利公司 Akt抑制剂
MX370448B (es) * 2013-03-11 2019-12-13 Merck Patent Gmbh Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa.
JP6398659B2 (ja) 2014-11-28 2018-10-03 アイシン・エィ・ダブリュ株式会社 歯形部品の製造方法および歯形部品製造装置

Also Published As

Publication number Publication date
PH12018502411A1 (en) 2019-09-16
DK3459953T3 (da) 2021-08-23
CN109153681B (zh) 2021-06-04
KR20180120777A (ko) 2018-11-06
MX2018014022A (es) 2019-04-04
HUE055846T2 (hu) 2021-12-28
JPWO2017200087A1 (ja) 2018-12-27
BR112018073721B1 (pt) 2023-12-05
AU2017265769B2 (en) 2019-05-02
BR112018073721A2 (pt) 2019-02-26
CA3024831C (fr) 2021-06-08
AU2017265769A1 (en) 2018-11-29
EP3459953A1 (fr) 2019-03-27
WO2017200087A1 (fr) 2017-11-23
MY185962A (en) 2021-06-14
HK1259613A1 (zh) 2019-12-06
TWI679202B (zh) 2019-12-11
ES2882018T3 (es) 2021-11-30
MA45048A (fr) 2019-03-27
US20190292190A1 (en) 2019-09-26
EP3459953B1 (fr) 2021-06-30
US10538528B2 (en) 2020-01-21
RU2713181C1 (ru) 2020-02-04
KR102149734B1 (ko) 2020-08-31
CN109153681A (zh) 2019-01-04
TW201742867A (zh) 2017-12-16
PT3459953T (pt) 2021-07-29
AU2017265769B9 (en) 2019-05-30
JP6576553B2 (ja) 2019-09-18
PL3459953T3 (pl) 2021-11-22
CA3024831A1 (fr) 2017-11-23
TWI732187B (zh) 2021-07-01
EP3459953A4 (fr) 2020-01-08
TW201920187A (zh) 2019-06-01

Similar Documents

Publication Publication Date Title
PH12018500437A1 (en) Novel pyrazolo [3,4-d] pyrimidine compounds or salt thereof
SG11201810360YA (en) Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative
CR20200441A (es) Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b
PH12014502721A1 (en) IMIDAZO[1,2-b] PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS
PH12017502171B1 (en) PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
MX2021008356A (es) Inhibidores de jak2 y alk2 y metodos para su uso.
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
MX2018002889A (es) Compuesto de pirimidina fusionada o sal del mismo.
GEP20156285B (en) Compounds and compositions as trk inhibitors
BR112013012502A2 (pt) pirrolopiridina ciclobutil substituída e derivados de pirrolopirimidina derivativos como inibidores de jak
ZA202205900B (en) 5-(2-(2,5-difluorophenyl)pyrrolidin-1 -yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancer
MX2014001239A (es) Compuestos de pirazolo [3,4-c] piridina y metodos de uso.
UA106054C2 (uk) ЗАМІЩЕНІ ПІРАЗОЛО[1,5-a]ПІРИМІДИНОВІ СПОЛУКИ ЯК ІНГІБІТОРИ TРK-КІНАЗИ
GEP20227434B (en) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer
MX364157B (es) Compuestos de pirazolo [1,5-a] pirimidina sustituidos como inhibidores de trk cinasa.
WO2017087808A8 (fr) Composés hétérocycliques inhibant l'activité kinase de mnk utiles pour le traitement de divers cancers
MX2012001420A (es) Derivados de pirrolo[1,2-b]piridazina como inhibidores de cinasa janus.
GEP20227344B (en) Pyrimidine compound as jak kinase inhibitor
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
NZ592429A (en) PHENANTHROINDOLIZIDINE DERIVATIVE AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
MX2021002051A (es) Imidazo[1,2-b]piridaziinas como inhibidores de trk.
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
PH12021551251A1 (en) Heterocyclic compound
MX2021000683A (es) Derivados de imidazo[1,2-b]piridazina como inhibidores de trk.
MX2010002475A (es) Derivados de alquilsulfona.